Usage of granulocyte colony-stimulating factor every 2 days is clinically useful and cost-effective for febrile neutropenia during early courses of chemotherapy

Author： Yakushijin Yoshihiro   Shikata Hisaharu   Takaoka Ikue   Horikawa Tamami   Takeuchi Kazuhito   Yamanouchi Jun   Azuma Taichi   Narumi Hiroshi   Hato Takaaki   Yasukawa Masaki  

Publisher： Springer Publishing Company

ISSN： 1341-9625

Source： International Journal of Clinical Oncology, Vol.16, Iss.2, 2011-04, pp. : 118-124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The safety of full-dose chemotherapy with secondary prophylactic granulocyte colony stimulating factor (G-CSF) following a prior cycle with febrile neutropenia

By Haim Nissim   Shulman Katerina   Goldberg Hadassah   Tsalic Medy  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 229-232

Humana Press, Inc

Access to resources Recommend Favorite

Colony-stimulating factors for chemotherapy-related febrile neutropenia are associated with improved prognosis in adult acute lymphoblastic leukemia

By            

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 730-736

Science Publishers

Access to resources Recommend Favorite

Possible Influence of Granulocyte Colony-Stimulating Factor and Recombinant Human Erythropoietin on Human Chorionic Gonadotropin Secretion during Chemotherapy for Choriocarcinoma - To the Editor

By Losch A.   Lahodny J.   Petru E.  

Gynecologic Oncology, Vol. 83, Iss. 1, 2001-10 ,pp. : 165-166

Elsevier

Access to resources Recommend Favorite

Successful induction of clinically competent dendritic cells from granulocyte colony-stimulating factor-mobilized monocytes for cancer vaccine therapy

By Ueda Yuji   Itoh Tsuyoshi   Fuji Nobuaki   Harada Sachio   Fujiki Hiroshi   Shimizu Keiji   Shiozaki Atsushi   Iwamoto Arihiro   Shimizu Takeshi   Mazda Osam   Kimura Takafumi   Sonoda Yoshiaki   Taniwaki Masafumi   Yamagishi Hisakazu  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 3, 2007-03 ,pp. : 381-389

Springer Publishing Company

Access to resources Recommend Favorite

The economics of febrile neutropenia: implications for the use of colony-stimulating factors

By Lyman G.H.   Kuderer N.   Greene J.   Balducci L.  

European Journal of Cancer, Vol. 34, Iss. 12, 1998-11 ,pp. : 1857-1864

Elsevier

Access to resources Recommend Favorite